Impact of EsTOCma on OCD Family Members
Launched by UNIVERSITY OF VALENCIA · Sep 23, 2024
Trial Information
Current as of July 31, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • having signed the informed consent
- • being over 18 years of age;
- • having an Android or iOS mobile device with Internet access
- • being a family member of a person diagnosed with OCD.
- Exclusion Criteria:
- • not completing one or more of the evaluation time points (pre- or post-intervention)
- • not finishing the intervention (experimental group only)
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Trial Officials
Gemma García-Soriano, PhD
Principal Investigator
Universitat de València
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported